RxDoctor Payments Data

Keith Stevens, MD

Anatomic Pathology & Clinical Pathology · Atlanta, GANPI 1548551674

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Roche Diagnostics Corporation at 39.3% of the total. Reporting peaked in 2022 at $297 and has fallen 91.7% since, to $25 in 2025.

$692in general payments, 2019–2025

Across 15 payments — averaging $46.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$272
  • AstraZeneca$240
  • Siemens Medical Solutions USA, Inc.$72
  • Tempus AI, Inc$59
  • Merck$25
  • Beckman Coulter, Inc.$25

What the payments were for

  • Food & beverage$692100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$692 in reported general payments places this provider in the 85th percentile of 223 anatomic pathology & clinical pathology providers in Georgia.

See all anatomic pathology & clinical pathology providers in Georgia

Medicare billing

Part B allowed, 2024
$123,582
Medicare patients
1,070
Services billed
3,115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →